Ameriprise
PGNX

Ameriprise’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Ameriprise’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-417,655
Closed -$1.59M – 3780
2020
Q1 		$1.59M Sell
417,655
-23,186
-5% -$99.9K ﹤0.01% 2595
2019
Q4 		$2.24M Sell
440,841
-14,922
-3% -$78.9K ﹤0.01% 2679
2019
Q3 		$2.3M Sell
455,763
-4,890
-1% -$24.4K ﹤0.01% 2636
2019
Q2 		$2.84M Sell
460,653
-23,343
-5% -$113K ﹤0.01% 2557
2019
Q1 		$2.25M Buy
483,996
+10,847
+2% +$49.1K ﹤0.01% 2687
2018
Q4 		$1.99M Sell
473,149
-2,205
-0.5% -$11.2K ﹤0.01% 2650
2018
Q3 		$2.98M Buy
475,354
+66,520
+16% +$511K ﹤0.01% 2647
2018
Q2 		$3.29M Buy
408,834
+38,895
+11% +$297K ﹤0.01% 2500
2018
Q1 		$2.76M Buy
369,939
+9,130
+3% +$60.7K ﹤0.01% 2556
2017
Q4 		$2.15M Sell
360,809
-3,623
-1% -$22K ﹤0.01% 2618
2017
Q3 		$2.68M Sell
364,432
-3,027
-0.8% -$19.2K ﹤0.01% 2457
2017
Q2 		$2.5M Sell
367,459
-339
-0.1% -$2.5K ﹤0.01% 2497
2017
Q1 		$3.47M Buy
+367,798
New +$3.67M ﹤0.01% 2289
2016
Q3 		– Sell
-37,037
Closed -$156K – 3862
2016
Q2 		$156K Sell
37,037
-602
-2% -$2.91K ﹤0.01% 3581
2016
Q1 		$164K Sell
37,639
-358
-0.9% -$1.59K ﹤0.01% 3567
2015
Q4 		$233K Sell
37,997
-202,736
-84% -$1.33M ﹤0.01% 3597
2015
Q3 		$1.38M Sell
240,733
-25,637
-10% -$197K ﹤0.01% 2822
2015
Q2 		$1.99M Buy
266,370
+58,584
+28% +$354K ﹤0.01% 2764
2015
Q1 		$1.24M Buy
207,786
+16,513
+9% +$104K ﹤0.01% 2817
2014
Q4 		$1.45M Buy
+191,273
New +$1.14M ﹤0.01% 2697
2014
Q3 		– Sell
-10
Closed – – 5940
2014
Q2 		$0 Buy
+10
New +$38 ﹤0.01% 5700
2013
Q4 		– Sell
-6,836
Closed -$34K – 5521
2013
Q3 		$34K Buy
6,836
+3,654
+115% +$19.8K ﹤0.01% 4042
2013
Q2 		$14K Buy
+3,182
New +$14.3K ﹤0.01% 4551

Other funds holding PGNX

ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $49.2B AUM 29.3% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Ameriprise's PGNX Position: Q2 2020 in Review

Ameriprise sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 417,655 shares — an estimated $1.59M sold.

Ameriprise first reported a position in PGNX in Q2 2013 and held it in 23 quarters. The position peaked at $3.47M in Q1 2017. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

  • Ameriprise reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • Ameriprise sold 417,655 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $1.59M.
  • Ameriprise first reported a position in Progenics Pharmaceuticals Inc in Q2 2013 and held it in 23 quarters.
  • Ameriprise's Progenics Pharmaceuticals Inc position peaked at $3.47M in Q1 2017.
  • 3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Ameriprise's 13F filing for Q2 2020, filed 14 Aug 2020.